Since TDE-mediated inhibition of ELK1 phosphorylation could promote the ubiquitination and degradation of PS1, we sought to assess whether TDE could alleviate amyloid pathology and cognitive deficits in APP23/PS45 model mice of AD. The gene discussed is ELK1; the disease is amyloidosis.